Información bibliográfica

GuíaWHO guidelines on leishmaniases: treatment of visceral leishmaniasis and post-kala-azar dermal leishmaniasis in eastern Africa and South-East Asia
Año de publicación2026
Institución emisoraWorld Health Organization

Recomendación

Nueva

Visceral leishmaniasis (VL) relapse in South-East Asia. For relapse cases that are not eligible for combination regimens, higher doses of liposomal amphotericin B (LAmB) up to a total dose of 15–20 mg/kg should be administered in three or four administrations.

Recomendado a favor

Condicional